FIGURE

Fig. 11

ID

ZDB-FIG-221114-25

Publication

Harms et al., 2021 - An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation

Other Figures

All Figure Page

Back to All Figure Page

Fig. 11

(A) EPI-X4 JM#21 is active in a mouse model of atopic dermatitis. Ears of BALB/c mice were applied every two days with mock or MC903 (2.5 nmol/ear). (B) EPI-X4 JM#21 (400 nmol/ear), AMD3100 (315 nmol/ear), dexamethasone (Dexa, 20 nmol/ear) or ethanol (EtOH) were applied topically daily. Representative photographs of ears are taken at day 12. Ear thickness (C) and the inflammatory score (D) were determined daily. Mice were used for MC903 (n = 8–16) and controls (n = 4–7). Data shown are mean ± SEM. ^####P ≤ 0.0001 compared to CTR + EtOH group, and ∗∗∗P ≤ 0.01, ∗∗∗∗P ≤ 0.0001 compared to MC903 + EtOH group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Pharm Sin B